Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.062 | 0.08 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.05 | 0.08 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.078 | 0.08 |
mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.09 |
mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.09 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.056 | 0.09 |
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |